-+ 0.00%
-+ 0.00%
-+ 0.00%
3 Indian Growth Stocks With Strong Earnings Forecasts Worth Watching
Share
Listen to the news

Singapore’s recent GDP upgrade, helped by strong AI related investment, has shifted attention back to companies with healthy growth potential. Investors are looking for stocks where earnings forecasts point higher and balance sheets look solid. The Healthy high growth potential screener highlights companies that currently fit that profile. This article walks through 3 stocks from the screener that stand out on growth quality and financial strength.

The three stocks covered next are just a starting sample, since the full Healthy high growth potential screen surfaced another 131 companies with similarly strong earnings forecasts and financial profiles that are not discussed here. If you want to identify and analyze candidates that best fit your own criteria, head straight to the Healthy high growth potential screener.

Monolithisch India (NSEI:MONOLITH)

Monolithisch India manufactures and supplies ramming mass, a heat resistant lining material used in induction furnaces across steel, metallurgy and foundry plants in India and Nepal. The company currently generates all its revenue, about ₹1,538 million, from the production of ramming mass and related products. Monolithisch India has a market cap of roughly ₹18.7b, which places it firmly in the mid sized bracket on the Indian market.

Monolithisch India catches attention because earnings have grown much faster than the wider Indian market and Basic Materials sector, supported by a rising net profit margin of 18.6%. Forecasts point to solid double digit earnings and revenue growth, and current and projected return on equity above 20% suggests the core business is converting that growth into healthy profitability. The trade off is a rich P/E multiple and a balance sheet funded entirely by higher risk external borrowing, alongside a relatively new management team and only one third independent directors. For investors, the key question is whether that growth and profitability profile justifies paying up for a business in a cyclical sector that is still tightening its governance and funding mix.

Monolithisch India’s rapid earnings momentum, together with a rich P/E and a fully debt funded balance sheet, suggests the headline story might be only half the picture. Get the full growth and funding context in the analyst forecasts for Monolithisch India

NSEI:MONOLITH Earnings & Revenue Growth as at Aug 2026
NSEI:MONOLITH Earnings & Revenue Growth as at Aug 2026

Build your own high growth shortlist

Monolithisch India and the other two stocks in this article all came from a single screener, but the real edge is creating filters that match your own approach. Use our flexible Screener to mix growth, quality and balance sheet metrics, or jump straight into our curated Investing Ideas.

Shaily Engineering Plastics (BSE:501423)

Shaily Engineering Plastics manufactures precision injection moulded components for healthcare, consumer, automotive and industrial customers, supplying products such as drug delivery pens, inhalers, pumps, kitchenware and sheet steel furniture. The company exports to around 40 countries and has been operating since 1980 from its base in Vadodara, India. Shaily Engineering Plastics currently has a market cap of about ₹158.8b, which places it firmly in the larger mid to upper bracket of Indian listed companies.

Shaily Engineering Plastics sits at the intersection of high growth healthcare devices and contract manufacturing, with products like GLP 1 injection pens already winning partnerships and regulatory approvals in the US, Canada and India. Earnings and revenue have been growing quickly, margins and return on equity are high, and analysts expect further strong growth supported by capacity expansion, automation and a pipeline of IP led devices. The flip side is a rich valuation and a balance sheet funded entirely by external borrowing, at a time when demand for new capacity and global healthcare volumes are not guaranteed. If you want exposure to scaled, export led healthcare plastics, this is a business worth understanding in more detail.

Shaily Engineering Plastics operates at the intersection of high growth healthcare devices and contract manufacturing, yet the rich valuation and fully borrowed balance sheet present meaningful trade offs. Get the full picture in the analysis report for Shaily Engineering Plastics

BSE:501423 Earnings & Revenue Growth as at Aug 2026
BSE:501423 Earnings & Revenue Growth as at Aug 2026

Enviro Infra Engineers (NSEI:EIEL)

Enviro Infra Engineers designs, builds, operates and maintains water and wastewater treatment plants and water supply projects for government authorities across India. Most of its revenue, about ₹11.35b, comes from EPC and operations and maintenance work in water and wastewater treatment, with a smaller contribution of roughly ₹106 million from renewable energy. The company has a market cap of about ₹37.85b, placing it firmly in the mid cap bracket.

Enviro Infra Engineers operates at the intersection of earnings growth and critical water infrastructure, with forecast earnings growth of 37.8% a year and revenue expected to grow 36.2% a year. The stock appears cheaper than many construction peers on a P/E basis, and recent HAM project wins under the Namami Gange programme have added long-term, contracted work with 15-year operations and maintenance commitments. The main risks are a volatile share price, earnings flattered by non-cash items and a balance sheet funded entirely by external borrowing, which all raise the stakes if growth stumbles. For investors willing to scrutinise the funding structure and earnings quality, the combination of growth forecasts and expanding project wins could make Enviro Infra Engineers a company of interest.

Enviro Infra Engineers’ rapid contract wins are linked with complex funding and earnings quality questions that many investors may be glossing over. Get the full risk reward breakdown in the 3 key rewards and 2 important warning signs (1 is major!)

NSEI:EIEL Earnings & Revenue Growth as at Aug 2026
NSEI:EIEL Earnings & Revenue Growth as at Aug 2026

Seeking Fresh Alternatives Before They Fly

New breakout stories often move quickly as momentum builds and fresh information gets priced in. Spot under the radar ideas before the crowd catches up and act now.

  • Chase reliable income while prices are still reasonable by scanning a curated set of resilient high yield stocks through the 440 dividend fortresses.
  • Hunt for early movers in next generation computing by tracking focused opportunities among 26 quantum computing stocks that could gain attention before valuations stretch.
  • Target future infrastructure candidates by reviewing carefully filtered 37 power grid technology and infrastructure stocks that may be affected if grid upgrades and electrification trends continue.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending